1 - 25 of 3
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Efficacy of Chronic Immunotherapy for Myelin Oligodendrocyte Glycoprotein-IgG DiseaseJohn Chen, Collin McClelland, Eric Eggenberger, Alfonso Lopez Chiriboga, Victoria Pelak, Heather Moss, Aubrey Gilbert, Michael Lee, Marie Acierno, Muhammad Bhatti, Jiraporn Jitprapaikulsan, Gregory Van Stavern, Divyanshu Dubey, Andrew McKeon, Jeffrey Bennett, Sean Pittock, Eoin Flanagan, Ore-ofe Ade...Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) is a recently established serum biomarker of demyelinating disease that is associated with recurrent CNS attacks. The optimal treatment to lower the risk of or prevent relapses is unknown. The goal of this study was to determine the efficacy...20190319_nanos_sciplatform3_02-video
2 Efficacy of Chronic Immunotherapy for Myelin Oligodendrocyte Glycoprotein-IgG DiseaseJohn Chen, Collin McClelland, Eric Eggenberger, Alfonso Lopez Chiriboga, Victoria Pelak, Heather Moss, Aubrey Gilbert, Michael Lee, Marie Acierno, Muhammad Bhatti, Jiraporn Jitprapaikulsan, Gregory Van Stavern, Divyanshu Dubey, Andrew McKeon, Jeffrey Bennett, Sean Pittock, Eoin Flanagan, Ore-ofe Ade...Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) is a recently established serum biomarker of demyelinating disease that is associated with recurrent CNS attacks. The optimal treatment to lower the risk of or prevent relapses is unknown. The goal of this study was to determine the efficacy...20190319_nanos_sciplatform3_02-abstract
3 Efficacy of Chronic Immunotherapy for Myelin Oligodendrocyte Glycoprotein-IgG DiseaseJohn Chen, Collin McClelland, Eric Eggenberger, Alfonso Lopez Chiriboga, Victoria Pelak, Heather Moss, Aubrey Gilbert, Michael Lee, Marie Acierno, Muhammad Bhatti, Jiraporn Jitprapaikulsan, Gregory Van Stavern, Divyanshu Dubey, Andrew McKeon, Jeffrey Bennett, Sean Pittock, Eoin Flanagan, Ore-ofe Ade...Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) is a recently established serum biomarker of demyelinating disease that is associated with recurrent CNS attacks. The optimal treatment to lower the risk of or prevent relapses is unknown. The goal of this study was to determine the efficacy...20190319_nanos_sciplatform3_02_slides
1 - 25 of 3